Call Today for a FREE Confidential Case Review - Toll-Free 24/7 (866) 920-0753

Anxiety, Insomnia Drugs Linked to Dementia in Elderly

Anxiety, Insomnia Drugs Linked to Dementia in Elderly

September 28, 2012 — A new study published in the British Medical Journal has found that elderly people who use anxiety and insomnia drugs have a 50% greater risk of developing dementia. These drugs, also known as benzodiazepines, include Ambien, Xanax, Restoril, Halcion, Klonopin, and more. Although official guidelines recommend that these drugs should only be used for a few weeks at a time, they are habit-forming, and elderly people often take them for several years.

Experts have a good understanding of the short-term effects of benzodiazepines, but they are still trying to understand the long-term effects. Although several studies have investigated this link, the results have been conflicting and inconclusive. Furthermore, good studies are difficult to conduct because the underlying problems that require treatment with benzodiazepines (insomnia, depression, and anxiety) could increase a person’s risk of dementia.

The researchers attempted a well-controlled study of dementia among new users of benzodiazepines. They screened study participants for 3-5 years before allowing them into the study; patients who started using benzodiazepines or showed symptoms of dementia were excluded. There were 1,063 individuals allowed into the study, and these people were followed for 15 years.

During the 15-year study, 253 of the 1,063 patients were diagnosed with dementia — 23% of non-benzodiazepine users were diagnosed with dementia, compared with 32% of benzodiazepine users. After the researchers controlled for confounding factors, they concluded that elderly people who start using benzodiazepines have a 50% increased risk of dementia.

The researchers also concluded that doctors and government health regulatory agencies should carefully consider the growing evidence linking benzodiazepines to an increased risk of dementia among the elderly.

It is unlikely that short-term use of these drugs increases the risk of dementia, but the study does raise concern about long-term use. The study was conducted in France, where 30% of people over 65 are prescribed benzodiazepines. These drugs are used less commonly in the United States, but many older Americans still use them chronically. The drugs are habit-forming, and they are often used for several years despite being indicated for only a few weeks at a time.

Do I have a Benzodiazepine Lawsuit?

The Schmidt Firm, PLLC is currently accepting benzodiazepine induced injury cases in all 50 states. If you or somebody you know has been injured by a benzodiazepine drug, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Defective Drug Litigation Group or call toll free 24 hours a day at (866) 920-0753.

Attention Lawyers: We consider a referral from another law firm to be one of the greatest compliments. If your firm is interested in referring us a case or for us to send you a list of previous award judgments and/or average referral fees, please visit the Lawyer Referral section of our website.

Free Case Evaluation

The Schmidt Firm, PLLC has been recognized as one of the nation’s leading plaintiffs’ law firms and handles cases in all 50 states. We are very proud of our legal achievements, but equally self-respecting of our firm’s reputation for providing personal attention to each and every client we represent.

No matter what type of case you have, you may contact us with confidence by filling out the email contact form below or calling us directly by dialing toll free 24 hrs/day (866) 920-0753.

*
*
*